KYMR · US market
Kymera Therapeutics Inc
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$9.16bnFinancials dated 30 June 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- -US$299.60m
- Latest-quarter run-rate earnings
- -US$244.84m
- Latest fiscal-year earnings
- -US$311.35m
- Trailing revenue
- US$105.00m
- Latest-quarter run-rate revenue
- US$260.00m
- Latest fiscal-year revenue
- US$39.21m
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- FMED · Fidelity Disruptive Medicine ETF1.99% weight · Holdings dated 31 May 2026
- XBI · State Street SPDR S&P Biotech ETF1.38% weight · Holdings dated 21 August 2026
- GURU · Global X Guru Index ETF1.04% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- IHSAX · The Hartford Small Company Fund Class A0.85% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- QUAZX · AB Small Cap Growth Portfolio Class Z0.63% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- IBB · iShares Biotechnology ETF0.62% weight · Holdings dated 19 August 2026
- HISCX · Hartford Small Cap Growth HLS Fund Class IA0.60% weight · Holdings dated 30 June 2026
- TNXT · T. Rowe Price Innovation Leaders ETF0.59% weight · Holdings dated 30 June 2026
- FTXH · First Trust Nasdaq Pharmaceuticals ETF0.59% weight · Holdings dated 30 June 2026
- CHCLX · AB Discovery Growth Fund Class A0.56% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 June 2026. Informational research, not investment advice.